BPC 157 Erectile Dysfunction Study: What the Evidence Actually Shows Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Overreach on Compounded Peptides Peptides and BPC 157 for Pain: PainExam Podcast Apple Podcasts